INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
PD

Pauling David

Chief Admin. Ofcr. & GCCIK 0002063633

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Tax withholding
F$5,903
277 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUTRO BIOPHARMA, INC.Chief Admin. Ofcr. & GC · Dec 29, 2025
9
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M
—
675 sh
Mar 4, 2026
Mar 6, 2026
traded Mar 4, 2026
+2d
SEC FORM 4

Evidence

13
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
675 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC FORM 4

Evidence

9
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Grant or award
A—
4,200 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

9
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Grant or award
A—
33.6K sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

13
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
500 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

13
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
842 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

13
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Tax withholding
F$11K
551 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

9
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
500 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

13
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Tax withholding
F$20K
970 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

17
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
2,356 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

21
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
842 sh
Mar 1, 2026Mar 3, 2026
traded Mar 1, 2026
+2dSEC FORM 4

Evidence

17
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
2,356 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

15
PD
Pauling DavidChief Admin. Ofcr. & GC
STROSUTRO BIOPHARMA, INC.
Grant or award
A—
7,200 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC FORM 4

Evidence